Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
posted on
Dec 22, 2020 09:58AM
Immuno ... BOOM! Thank you for some issues and answers, that I can't intelligently/effectively articulate. We are still in Covid vaccine/treatment "infancy" as far as our understandings, in short, striving for the best answers.
Question for you, do you feel getting to the root of the Covid-family entry (ACE2 receptors) and potentially "treating" those infected, has potential to be an absolute game changer?